Latest profit margin for Original BioMedicals , Ltd.: -50009.97% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Original BioMedicals , Ltd. (6483.TWO) currently reports a profit margin of -50009.97% as of June 2026. That compares with -77299.33% in the prior-year period — up 35.3% year over year. That is below the sector sector average of 13.4%. Use the charts on this page to explore Original BioMedicals , Ltd.'s profit margin history and peer comparisons.
Original BioMedicals , Ltd.'s profit margin increased from -77299.33% to -50009.97% — a 35.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Original BioMedicals , Ltd.'s profit margin of -50009.97% is lower than the its sector sector average of 13.4%. That is roughly 373213.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Original BioMedicals , Ltd.'s current -50009.97% should be judged against industry norms (sector average: 13.4%) and against 6483.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -50009.97%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.4%. From there, open related valuation or income-statement pages for Original BioMedicals , Ltd., and consider following 6483.TWO for alerts when major investors trade the stock.